|
Volumn 24, Issue 4, 2004, Pages 909-917
|
Dendritic cell-based immunotherapy of cancer with carcinoembryonic antigen-derived, HLA-A24-restricted CTL epitope: Clinical outcomes of 18 patients with metastatic gastrointestinal or lung adenocarcinomas.
a a a a a a a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CANCER VACCINE;
CARCINOEMBRYONIC ANTIGEN;
GRANULOCYTE COLONY STIMULATING FACTOR;
HLA A ANTIGEN;
HLA A24 ANTIGEN;
ADENOCARCINOMA;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
CYTOTOXIC T LYMPHOCYTE;
DELAYED HYPERSENSITIVITY;
DENDRITIC CELL;
FEASIBILITY STUDY;
FEMALE;
GASTROINTESTINAL TUMOR;
HUMAN;
IMMUNOLOGY;
IMMUNOTHERAPY;
LUNG TUMOR;
MALE;
METASTASIS;
MIDDLE AGED;
TREATMENT OUTCOME;
ADENOCARCINOMA;
ADULT;
AGED;
CANCER VACCINES;
CARCINOEMBRYONIC ANTIGEN;
DENDRITIC CELLS;
FEASIBILITY STUDIES;
FEMALE;
GASTROINTESTINAL NEOPLASMS;
GRANULOCYTE COLONY-STIMULATING FACTOR;
HLA-A ANTIGENS;
HUMANS;
HYPERSENSITIVITY, DELAYED;
IMMUNOTHERAPY;
LUNG NEOPLASMS;
MALE;
MIDDLE AGED;
T-LYMPHOCYTES, CYTOTOXIC;
TREATMENT OUTCOME;
MLCS;
MLOWN;
|
EID: 1842830792
PISSN: 10196439
EISSN: None
Source Type: Journal
DOI: 10.3892/ijo.24.4.909 Document Type: Article |
Times cited : (74)
|
References (0)
|